Gonzalez-Parra G, Arenas A
Computation (Basel). 2024; 11(2).
PMID: 38957648
PMC: 11218807.
DOI: 10.3390/computation11020036.
Bankers L, OBrien S, Tapay D, Ho E, Armistead I, Burakoff A
Emerg Infect Dis. 2024; 30(6):1182-1192.
PMID: 38781929
PMC: 11139003.
DOI: 10.3201/eid3006.231427.
Vulturar D, Moaca L, Neag M, Mitre A, Alexescu T, Gherman D
J Pers Med. 2024; 14(4).
PMID: 38672984
PMC: 11050903.
DOI: 10.3390/jpm14040358.
Pavia C, Plummer M
Methods Microbiol. 2024; 50:269-279.
PMID: 38620783
PMC: 8797165.
DOI: 10.1016/bs.mim.2021.11.001.
Khemiri H, Mangone I, Gdoura M, Mefteh K, Chouikha A, Fares W
Virus Res. 2024; 344:199353.
PMID: 38490581
PMC: 10966772.
DOI: 10.1016/j.virusres.2024.199353.
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants.
Ghildiyal T, Rai N, Rawat J, Singh M, Anand J, Pant G
J Immunol Res. 2024; 2024:9125398.
PMID: 38304142
PMC: 10834093.
DOI: 10.1155/2024/9125398.
Tracking the structure and sentiment of vaccination discussions on Mumsnet.
Silva M, Skeva R, House T, Jay C
Soc Netw Anal Min. 2023; 13(1):152.
PMID: 38026264
PMC: 10657328.
DOI: 10.1007/s13278-023-01155-z.
SARS-CoV-2 excretion kinetics in nasopharyngeal and stool samples from the pediatric population.
Khemiri H, Gdoura M, Halima S, Krichen H, Camma C, Lorusso A
Front Med (Lausanne). 2023; 10:1226207.
PMID: 38020093
PMC: 10643538.
DOI: 10.3389/fmed.2023.1226207.
The effect of the earliest COVID-19 outbreak on survival in uninfected advanced NSCLC patients receiving chemotherapy in Jiangsu Province, China: A retrospective cohort study.
Lu H, Wang Y, Feng G, Shen C, Zhou X, Han J
Medicine (Baltimore). 2023; 102(39):e34559.
PMID: 37773874
PMC: 10545141.
DOI: 10.1097/MD.0000000000034559.
Assessing the evolution of SARS-CoV-2 lineages and the dynamic associations between nucleotide variations.
Gupta A, Basu R, Bashyam M
Access Microbiol. 2023; 5(7).
PMID: 37601437
PMC: 10436015.
DOI: 10.1099/acmi.0.000513.v3.
The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37.
Nabaes Jodar M, Torres C, Mojsiejczuk L, Acuna D, Valinotto L, Goya S
Viruses. 2023; 15(6).
PMID: 37376681
PMC: 10305049.
DOI: 10.3390/v15061382.
SARS-CoV-2 in mink farms in British Columbia, Canada: A report of two outbreaks in 2020-2021.
Paiero A, Newhouse E, Chan E, Clair V, Russell S, Zlonsnik J
Can Commun Dis Rep. 2023; 48(6):274-281.
PMID: 37333572
PMC: 10274534.
DOI: 10.14745/ccdr.v48i06a05.
The Role of "Hierarchical and Classified Prevention and Control Measures (HCPC)" Strategy for SARS-CoV-2 Delta Variant in Guangzhou: A Modeling Study.
Ma Y, Wang H, Huang Y, Chen C, Liang S, Ma M
J Epidemiol Glob Health. 2023; 13(2):303-312.
PMID: 37258853
PMC: 10231852.
DOI: 10.1007/s44197-023-00108-1.
Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020-2022 Survey of the Pediatric Rheumatology Association of Japan.
Wakiguchi H, Kaneko U, Sato S, Imagawa T, Narazaki H, Miyamae T
Viruses. 2023; 15(5).
PMID: 37243292
PMC: 10221643.
DOI: 10.3390/v15051205.
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza.
Spindel J, Furmanek S, Chandler T, Ramirez J, Cavallazzi R
Pathogens. 2023; 12(4).
PMID: 37111457
PMC: 10142714.
DOI: 10.3390/pathogens12040571.
Covid-19: virology, variants, and vaccines.
Young M, Crook H, Scott J, Edison P
BMJ Med. 2023; 1(1):e000040.
PMID: 36936563
PMC: 9951271.
DOI: 10.1136/bmjmed-2021-000040.
Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study.
Wu J, Wang L, Hua Y, Li M, Zhou L, Bates D
J Med Internet Res. 2023; 25:e45419.
PMID: 36812402
PMC: 10131634.
DOI: 10.2196/45419.
Origin and evolution of SARS-CoV-2.
Pagani I, Ghezzi S, Alberti S, Poli G, Vicenzi E
Eur Phys J Plus. 2023; 138(2):157.
PMID: 36811098
PMC: 9933829.
DOI: 10.1140/epjp/s13360-023-03719-6.
Delta Variant: Partially Sensitive To Vaccination, but Still Worth Global Attention.
Zhang M, He Y, Jie Z
J Transl Int Med. 2023; 10(3):227-235.
PMID: 36776232
PMC: 9901554.
DOI: 10.2478/jtim-2022-0026.
Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?.
Rosenstrom E, Mele J, Ivy J, Mayorga M, Patel M, Hassmiller Lich K
PNAS Nexus. 2023; 1(1):pgab004.
PMID: 36712803
PMC: 9801966.
DOI: 10.1093/pnasnexus/pgab004.
